A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.
Decensi A, Bonanni B, Baglietto L, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Robertson C, Marinucci I, Mariette F, Sandri MT, Daldoss C, Bianco V, Buttarelli M, Cazzaniga M, Franchi D, Cassano E, Omodei U.
Decensi A, et al. Among authors: ramazzotto f.
Clin Cancer Res. 2004 Jul 1;10(13):4389-97. doi: 10.1158/1078-0432.CCR-04-0087.
Clin Cancer Res. 2004.
PMID: 15240527
Clinical Trial.